Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking therapy may ease symptoms of functional movement disorder

NCT ID NCT06873698

Symptom relief Sponsor: Rhode Island Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests whether a type of talking therapy called neurobehavioral therapy (NBT) can help people with motor functional neurological disorder (mFND), a condition where the brain has trouble sending the right signals to the body, causing movement problems. The trial will compare 12 weekly sessions of NBT plus standard care to standard care alone in 40 adults. Researchers will track symptoms, functioning, and quality of life over a year to see if NBT leads to meaningful improvement.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Neurobehavioral therapy (NBT)
What this could lead to
If it works, this could provide an effective, non-drug treatment option for people with functional motor disorder, reducing symptoms and improving daily life.
What could go wrong
This is a small pilot study with only 40 participants, so results may not apply to everyone. The therapy requires weekly sessions for 12 weeks, and not everyone may respond.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals diagnosed with Motor Functional Neurological Disorder (mFND) * Individuals aged 18-100 years * At least 1 mFND symptom during the year prior to enrollment Exclusion Criteria: * Current or past year self-injurious behavior * Current suicidality (PHQ-9 question 9 rated as 1 or above) * Current or past year psychosis * Pending litigation or current application for long term disability * Active substance or alcohol use disorders (dependence), at the discretion of the investigator if they preclude participation in the study * Serious illness requiring systemic treatment or hospitalization; the participant either completes therapy or is clinically stable on therapy, for at least 30 days prior to study entry * Inability to fill out the self-report surveys * Inability or unwillingness to participate in NBT and assigned homework * Currently enrolled in NBT aimed at mFND

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Functional neurological disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

conversion disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Functional neurological disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Rhode Island Hospital

    RECRUITING

    Providence, Rhode Island, 02903, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.